Avoidable research waste in dermatology: what are the solutions?

In the last editorial, I provided examples of research waste in dermatology and suggested that it was due to a system failure rather than just a few "bad apples". Here, I focus on possible solutions, mainly in relation to clinical trials, building on examples from work at the Centre of Evidence-Based Dermatology (CEBD) and other research groups.